Lung‐Targeted Rnai Therapeutics: Lung‐Endothelium‐Targeted Nanoparticles Based on a pH‐Sensitive Lipid and the GALA Peptide Enable Robust Gene Silencing and the Regression of Metastatic Lung Cancer (Adv. Funct. Mater. 18/2019)
Advanced Functional Materials - United Kingdom
doi 10.1002/adfm.201970121
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 1, 2019
Authors
Publisher
Wiley